by Universitat Pompeu Fabra – Barcelona JZL184 administration regresses cardiac hypertrophy and the expression of cardiac Cnr1 alterations of complete deletion (CD) mice. Credit: eLife (2022). DOI: 10.7554/eLife.72560 Using an in vivo model that mimics the genetic alteration of Williams-Beuren syndrome, researchers from the UPF’s Neuropharmacology Laboratory—NeuroPhar, in collaboration with several other universities, found alterations in the...